Drug Profile

Copper sulfate ophthalmic - iVeena Delivery Systems

Alternative Names: Copper sulfate eye drops - iVeena Delivery Systems; IVMED-80

Latest Information Update: 15 Nov 2022

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator iVeena Delivery Systems
Class Contraceptives; Eye disorder therapies
Mechanism of Action Undefined mechanism

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

Yes - Keratoconus
New Molecular Entity No

Highest Development Phases

Phase I/II Keratoconus

Most Recent Events

15 Nov 2022 Chemical structure information added
25 Aug 2022 iVeena Delivery Systems enters into a strategic licensing agreement with Glaukos Corporation to develop and commercialize IVMED 80 for Keratoconus globally
27 Oct 2020 Topline adverse events and pharmacokinetics data from a phase I/II trial in Keratoconus released by iVeena

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com